A novel immune signature predicts immunotherapy responsiveness and reveals the landscape of the tumor immune microenvironment in head and neck squamous cell carcinoma

A novel immune signature predicts immunotherapy responsiveness and reveals the landscape of the tumor immune microenvironment in head and neck squamous cell carcinoma

Background: Immune-checkpoint blockade (ICB) has been routinely implemented to treat head and neck squamous cell carcinoma (HNSCC) patients. However, only a few patients benefit from immune checkpoint inhibitor (ICI) therapies.Methods: In this study, we used a combined cohort (including the GSE41613...

Full description

Bibliographic Details
Main Authors: Qiwei Wang, Yinan Zhao, Fang Wang, Guolin Tan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Genetics
Subjects:
HNSCC
immune signature
immunotherapy
prognosis
tumor immune microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.1051051/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.1051051/full

Similar Items